Musa Yilmaz, MD
Department of Leukemia, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2016 | Baylor College of Medicine, Houston, TX, USA, Fellowship, Hematology and Oncology |
| 2013 | The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Fellowship, Leukemia |
| 2012 | University of Texas Medical School at Houston, Houston, TX, USA, Residency, Internal Medicine |
| 2008 | Marmara University School of Medicine, Istanbul, TUR, MD, Medicine |
Board Certifications
| 2016 | American Internal Medicine Board Certification |
Experience & Service
Institutional Committee Activities
Associate Member, Institutional Review Board (IRB) 1, 2019 - Present
Member, Clinical Research Committee (CRC #4), 2017 - 2019
Selected Publications
Peer-Reviewed Articles
- Jabbour E, Short NJ, Jorgensen JL, Yilmaz M, Ravandi F, Wang SA, Thomas DA, Khoury J, Champlin RE, Khouri I, Kebriaei P, O'Brien SM, Garcia-Manero G, Cortes JE, Sasaki K, Dinardo CD, Kadia TM, Jain N, Konopleva M, Garris R, Kantarjian HM. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer 123(2):294-302, 2017. e-Pub 2016. PMID: 27602508.
- Yilmaz M, Lahoti A, O'Brien S, Nogueras-González GM, Burger J, Ferrajoli A, Borthakur G, Ravandi F, Pierce S, Jabbour E, Kantarjian H, Cortes JE. Estimated glomerular filtration rate changes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Cancer 121(21):3894-904, 2015. e-Pub 2015. PMID: 26217876.
- Mattiuzzi G, Yilmaz M, Kantarjian H, Borthakur G, Konopleva M, Jabbour E, Brown Y, Pierce S, Cortes J. Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia. J Infect Chemother 21(9):663-7, 2015. e-Pub 2015. PMID: 26141814.
- Yilmaz M, Kantarjian H, Jabbour E, O'Brien S, Borthakur G, Verstovsek S, Garcia-Manero G, Ravandi F, Burger J, Pierce S, Quintas-Cardama A, Cortes J. Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trials. Clin Lymphoma Myeloma Leuk 13(6):693-9, 2013. e-Pub 2013. PMID: 24060289.
- Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 48(9):1218-23, 2013. e-Pub 2013. PMID: 23503529.
Invited Articles
- Yilmaz M, Kantarjian H, Jabbour E. Treatment of acute lymphoblastic leukemia in older adults: now and the future. Clin Adv Hematol Oncol 15(4):266-274, 2017. PMID: 28591103.
- Yilmaz M, Jabbour E. Tyrosine Kinase Inhibitors Early in the Disease Course: Lessons From Chronic Myelogenous Leukemia. Semin Oncol 42(6):876-86, 2015. e-Pub 2015. PMID: 26615132.
- Yilmaz M, Richard S, Jabbour E. The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia. Ther Adv Hematol 6(5):253-61, 2015. PMID: 26425338.
- Yilmaz M, Abaza Y, Jabbour E. Selecting the best frontline treatment in chronic myeloid leukemia. Curr Hematol Malig Rep 10(2):145-57, 2015. PMID: 25921387.
Other Articles
- Pacheco JM, Yilmaz M, Rice L How low is too low: Statin induced hemolysis. Am J Hematol 91(2):267, 2016. PMID: 26147873.
- Yilmaz M, Ibarra J, Musher BL Prolapsed gastric gastrointestinal stromal tumor: a rare cause of biliary obstruction and acute pancreatitis. Clin Gastroenterol Hepatol 13(4):e35-6, 2015. PMID: 25251573.
- Fernando RR, Yilmaz M, Higgins JP The changing electrocardiogram in Brugada syndrome. Int J Cardiol 163(2):e36-7, 2013. PMID: 23017816.
Book Chapters
- Yilmaz M, Udden M. Acute Lymphoblastic Leukemia. In: Tumor Board Review, Guidelinnes and Case Reviews in Oncology. second. Demos Medical, 348-356, 2015.